These emerging treatments bridge the gap between biohacking and clinical medicine. Here's an honest assessment of what the evidence supports, what's promising but preliminary, and what's not worth your money yet.
Walk into any men's health optimization clinic in 2026 and you'll hear terms that would have sounded like science fiction a decade ago: NAD+ infusions, growth hormone secretagogues, peptide stacks, cellular regeneration protocols. The anti-aging industry has merged with the men's health treatment space, and the result is a fascinating — and confusing — landscape.
Some of these treatments have real clinical evidence behind them. Others are promising but early-stage. And some are expensive placebo wrapped in good marketing. This article sorts them honestly, using the same evidence standards we apply to every treatment on MenRxFast.
Nicotinamide adenine dinucleotide (NAD+) is a coenzyme found in every living cell. It's essential for cellular energy production (through its role in the mitochondrial electron transport chain), DNA repair, sirtuin activation (proteins involved in aging regulation), and hundreds of other enzymatic reactions.
NAD+ levels decline with age — roughly 50% decline between ages 40 and 60 in some measurements. This decline correlates with reduced cellular energy, impaired DNA repair, and accelerated aging markers. The therapeutic hypothesis is straightforward: restore youthful NAD+ levels, and cellular function improves.
IV infusion: The most direct method. Bypasses the gut, delivering NAD+ straight to the bloodstream. Often administered in clinical settings over 2–4 hours. Most expensive option ($250–$1,000+ per session).
Subcutaneous injection: Self-administered at home, similar to peptide protocols. Growing in popularity through telehealth platforms. More affordable than IV, with good bioavailability.
Oral precursors (NMN, NR): Nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) are NAD+ precursors that your body converts to NAD+. Available as supplements. The most accessible and affordable option, though bioavailability is debated.
Care Bare Rx offers NAD+ protocols as part of their multi-category platform, and Breeze Meds specializes in NAD+ treatment. For an in-depth look at the full longevity and cognitive optimization landscape, AntiAgingBrain is the dedicated deep-dive resource.
For men already on TRT, GLP-1, or other core treatments, NAD+ occupies a complementary role — it's not treating the same conditions, but it's supporting the cellular infrastructure that makes other treatments work more effectively. Think of it as optimizing the engine (cellular energy) so that the fuel (testosterone, medications) burns more efficiently.
The practical caveat: if your metabolic health, hormones, and sexual function aren't addressed yet, NAD+ shouldn't be a priority. Fix the foundation first. NAD+ is a Phase 6 intervention in our optimization protocol for a reason.
Sermorelin is a growth hormone-releasing hormone (GHRH) analog — it stimulates your pituitary gland to produce and release more growth hormone naturally. This is fundamentally different from injecting synthetic human growth hormone (HGH) directly, which carries regulatory restrictions, higher side-effect risk, and a long list of contraindications.
Growth hormone levels decline steadily after age 30, and this decline contributes to reduced muscle mass, increased body fat, slower recovery, poorer sleep quality, and decreased skin elasticity. Sermorelin aims to restore more youthful GH pulses without the risks of direct GH replacement.
Sermorelin has been FDA-approved (for growth hormone deficiency in children) and studied in adults. The adult evidence shows improvements in body composition (reduced visceral fat, increased lean mass), sleep quality (particularly deep-wave sleep enhancement), exercise recovery, and skin quality. The evidence is moderate in quality — stronger than most supplements but not as robust as, say, the TRT or GLP-1 literature.
Yucca Health includes sermorelin in their protocols alongside GLP-1 and other treatments.
Strut Health also offers sermorelin as part of their men's health platform. For the broader anti-aging treatment landscape, AntiAgingBrain covers the full range of options.
Beyond sermorelin, several peptides are gaining traction in men's health optimization circles. Here's an honest assessment of each:
A synthetic peptide derived from a protein in gastric juice. Used for injury recovery, gut healing, and anti-inflammatory effects. The animal data is extensive and impressive. Human clinical trials are minimal — most use is extrapolated from preclinical research. Widely available through peptide clinics. Evidence level: intriguing preclinical, limited human data.
A melanocortin receptor agonist approved by the FDA (as Vyleesi) for hypoactive sexual desire disorder in women. Used off-label in men for libido enhancement. Works through the central nervous system rather than vascular mechanisms (unlike PDE5 inhibitors), making it useful for men whose ED has a desire/arousal component rather than purely vascular. Evidence level: FDA-approved for different indication; off-label male use has supporting data but limited controlled trials.
Growth hormone-releasing peptides often stacked together. CJC-1295 (with DAC) provides sustained GH release; ipamorelin provides a GH pulse. Used for body composition improvement, recovery, and sleep. Similar to sermorelin in concept but using different receptor mechanisms. Evidence level: moderate, with more clinical familiarity around ipamorelin.
| Treatment | Evidence Quality | Primary Benefit | Cost Range (Monthly) |
|---|---|---|---|
| NAD+ (IV/injection) | Moderate (strong preclinical, growing human data) | Cellular energy, DNA repair, anti-aging markers | $200–$500 |
| NAD+ precursors (NMN/NR oral) | Moderate (accessible, less direct delivery) | Same as above, lower bioavailability | $50–$150 |
| Sermorelin | Moderate (FDA-approved compound, adult off-label) | GH optimization, body composition, sleep | $150–$400 |
| BPC-157 | Low-moderate (strong animal, limited human) | Injury recovery, gut healing | $100–$250 |
| PT-141 | Moderate (FDA-approved different indication) | Libido enhancement, central arousal | Per-use: $50–$100 |
| CJC-1295/Ipamorelin | Moderate | GH release, recovery, sleep | $200–$500 |
If you're reading this article, you're probably already treating or planning to treat one or more core men's health conditions. Here's where anti-aging and peptide interventions fit in the hierarchy:
Address first: Weight management (GLP-1 if needed), hormonal optimization (TRT or enclomiphene), sexual health (PDE5 inhibitors), hair preservation (finasteride/minoxidil). These have the strongest evidence and the most immediate impact on quality of life.
Add when foundation is solid: NAD+ supplementation (oral precursors are the most accessible entry point), sermorelin (if GH optimization is a priority based on symptoms and goals), and specific peptides based on individual needs (BPC-157 for injury recovery, PT-141 for central arousal).
Avoid: Stacking multiple untested peptides simultaneously without a clear clinical rationale. Starting anti-aging protocols before metabolic and hormonal foundations are addressed. Spending $500+/month on peptides while ignoring basic sleep, exercise, and nutrition optimization.
Multi-category platforms make this layered approach easier. Care Bare Rx offers GLP-1, ED, and NAD+ on one platform. Yucca Health provides GLP-1 alongside sermorelin and other peptides. And PeterMD offers the broadest range — TRT, ED, hair loss, GLP-1, peptides, and even ketamine therapy — through their comprehensive protocols.
The merger of anti-aging science and men's health treatment is real, and some of it is legitimately exciting. NAD+ restoration has a strong biological rationale and growing human evidence. Sermorelin offers a safer path to growth hormone optimization than direct GH replacement. And specific peptides address gaps (injury recovery, central arousal) that traditional men's health treatments don't cover.
But excitement should be tempered with evidence standards. These are still emerging treatments, and the evidence base — while promising — doesn't yet match what we have for TRT, PDE5 inhibitors, finasteride, or GLP-1 medications. They belong in your protocol, but they belong in the later phases, after the foundation is solid.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Peptide and anti-aging therapies should be administered under qualified medical supervision. Regulatory status varies by compound and jurisdiction.
Affiliate Disclosure: MenRxFast may earn a commission from qualifying purchases through affiliate links in this article. This does not affect our editorial independence or content accuracy.
© 2026 MenRxFast. All rights reserved.